FindTrial
Sign In

Phase II study: Radiofrequency ablation of irresectable locally advanced pancreatic cancer

Phase II study: Radiofrequency ablation of irresectable locally advanced pancreatic cancer - Phase II: RFA of LAPC

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON36420
Enrollment
15
Registered
2011-03-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer of the pancreas Pancreatic cancer

Interventions

The investigational treatment of this study is radiofrequency ablation. Radiofrequency ablation of the pancreatic tumours will be produced through application of high frequency alternating current f

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients with locally advanced pancreatic cancer 2. No evidence of systemic metastasis, CT scan within 1 month prior to inclusion 3. No serious medical or psychological condition precluding radiofrequency ablation 4. Fully informed written consent given 5. Patients willing to attend for three months follow-up

Exclusion criteria

Exclusion criteria: 1. Patients younger than 18 years 2. Pregnancy 3. Patients with distant metastasis

Design outcomes

Primary

MeasureTime frame
Primary outcome parameter of the phase II study is feasibility and safety. The study will have a follow-up period of 3 months.—

Secondary

MeasureTime frame
Secondary study parameters are tumour downstaging, VAS painscore and hospital stay.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)